drs. M. Tamminga

No picture available
E-mail:
m.tamminga umcg.nl

Research

  1. 2020
  2. Weber, S., Spiegl, B., Perakis, S. O., Ulz, C. M., Abuja, P. M., Kashofer, K., ... Heitzer, E. (2020). Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling. Cancers, 12(6), [1588]. https://doi.org/10.3390/cancers12061588
  3. 2019
  4. Pantel, K., Terstappen, L. W. M. M., manaresi, N., Groen, H. J. M., Tamminga, M., Schuuring, E., ... Schlange, T. (2019). Standardization and clinical implementation of liquid biopsy assays - IMI's CANCER-ID. Poster session presented at AACR annual meeting 2019, Atlanta, United States.
  5. 2018
  6. 2017
  7. 2016

ID: 15656079